CLINICAL_TRIALS
trial_result
· 2024-10-08
Clinical Trial Update: Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain [Phase 3]
Summary
Phase 3 trial results for an extended-release liposomal dexamethasone formulation in knee osteoarthritis have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taiwan Liposome Company | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2024-10-08